The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A Patient - EP2395968

The patent EP2395968 was granted to Boehringer Ingelheim on Jan 17, 2024. The application was originally filed on Feb 11, 2010 under application number EP10703652A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2395968

BOEHRINGER INGELHEIM
Application Number
EP10703652A
Filing Date
Feb 11, 2010
Status
Granted And Under Opposition
Dec 15, 2023
Publication Date
Jan 17, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (19)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BRAND MURRAY FULLEROct 17, 2024BRAND MURRAY FULLERADMISSIBLE
BRAND MURRAY FULLER SERVICESOct 17, 2024BRAND MURRAY FULLERADMISSIBLE
GENERICS UKOct 17, 2024TER MEER STEINMEISTER & PARTNERADMISSIBLE
HGFOct 17, 2024HGFADMISSIBLE
LUIGIOct 17, 2024TER MEER STEINMEISTER & PARTNERADMISSIBLE
MAIWALDOct 17, 2024MAIWALDADMISSIBLE
STADA ARZNEIMITTELOct 17, 2024KERNEBECKADMISSIBLE
ZBM PATENTSOct 17, 2024ZBM PATENTS ZEAADMISSIBLE
AERAOct 16, 2024AERAADMISSIBLE
AERAOct 16, 2024BARDEHLE PAGENBERG SLADMISSIBLE
GALENICUM HEALTH SLUOct 16, 2024GALENICUM HEALTH SLUADMISSIBLE
HAMM & WITTKOPPOct 16, 2024HAMM & WITTKOPPADMISSIBLE
KRAUS & LEDERER PARTGMBBOct 16, 2024KRAUS & LEDERER PARTGMBBADMISSIBLE
TEVA PHARMACEUTICALSOct 16, 2024VON KAUFFMANNADMISSIBLE
BULLE DROct 15, 2024KUTZENBERGER WOLFF & PARTNERADMISSIBLE
CAMULONOct 14, 2024REDDIE & GROSEADMISSIBLE
ZENTIVA KSOct 14, 2024REDDIE & GROSEADMISSIBLE
POLPHARMAOct 10, 2024ELKINGTON AND FIFEADMISSIBLE
SANDOZOct 10, 2024ELKINGTON AND FIFEADMISSIBLE

Patent Citations (48) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO0127128
DESCRIPTIONWO03099836
DESCRIPTIONWO2005092877
DESCRIPTIONWO2006034489
DESCRIPTIONWO2006064033
DESCRIPTIONWO2006117359
DESCRIPTIONWO2006117360
DESCRIPTIONWO2006120208
DESCRIPTIONWO2007025943
DESCRIPTIONWO2007028814
DESCRIPTIONWO2007031548
DESCRIPTIONWO2007093610
DESCRIPTIONWO2007128749
DESCRIPTIONWO2008020011
DESCRIPTIONWO2008049923
DESCRIPTIONWO2008055870
DESCRIPTIONWO2008055940
EXAMINATIONEP2187879
EXAMINATIONUS2005209166
EXAMINATIONUS2007249544
EXAMINATIONUS2008234367
EXAMINATIONWO2005092877
EXAMINATIONWO2009022007
INTERNATIONAL-SEARCH-REPORTWO2007128749
INTERNATIONAL-SEARCH-REPORTWO2008116179
OPPOSITIONCA2557801
OPPOSITIONEP2187879
OPPOSITIONUS2005209166
OPPOSITIONUS2007249544
OPPOSITIONUS2008234367
OPPOSITIONUS2009023913
OPPOSITIONWO0151463
OPPOSITIONWO2005092877
OPPOSITIONWO2006117359
OPPOSITIONWO2007128749
OPPOSITIONWO2008055940
OPPOSITIONWO2008090210
OPPOSITIONWO2008116179
OPPOSITIONWO2008116195
OPPOSITIONWO2009022007
OPPOSITIONWO2010092124
OPPOSITIONWO2010092126
OTHEREP2187879
OTHERUS2005209166
OTHERUS2007249544
OTHERUS2008234367
OTHERWO2005092877
OTHERWO2009022007

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents